ArticleFrontiers in allergy2025

Real-life effectiveness of once-daily single-inhaler triple therapy (FF-UMEC-VI) after switching from dual therapy (ICS-LABA) in patients with symptomatic asthma: trelegy ellipta for real asthma control study.

Yoshitomo Kushima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.